|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2000-9-29
|
|
pubmed:abstractText |
Low bone mineral density (BMD) is a common complication of Crohn's disease and may lead to increased morbidity and mortality because of fractures. We investigated the effect of treatment with the bisphosphonate alendronate on bone mass and markers of bone remodeling in patients with Crohn's disease.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0016-5085
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
119
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
639-46
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10982756-Adult,
pubmed-meshheading:10982756-Alendronate,
pubmed-meshheading:10982756-Biological Markers,
pubmed-meshheading:10982756-Bone Density,
pubmed-meshheading:10982756-Bone and Bones,
pubmed-meshheading:10982756-Crohn Disease,
pubmed-meshheading:10982756-Double-Blind Method,
pubmed-meshheading:10982756-Female,
pubmed-meshheading:10982756-Hip Joint,
pubmed-meshheading:10982756-Humans,
pubmed-meshheading:10982756-Incidence,
pubmed-meshheading:10982756-Lumbar Vertebrae,
pubmed-meshheading:10982756-Male,
pubmed-meshheading:10982756-Middle Aged,
pubmed-meshheading:10982756-Spinal Fractures
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease.
|
|
pubmed:affiliation |
Department of Medical Gastroenterology, The Abdominal Center, Rigshospitalet, Copenhagen, Denmark. khaderslev@dadlnet.dk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
